STAT3 and neoplasm: The enhanced interaction between T372-phosphorylated EZH2 and STAT3 reduced STAT3 phosphorylation, downregulating interleukin 6 receptor expression and inhibiting the cell proliferation and migration of epithelial ovarian cancer cells in vitro and decreasing ovarian xenograft tumor growth in vivo [44].